Along this line of research, we have recently performed an in silico study by interrogating publicly available whole-genome transcriptomic databases in order to evaluate the prognostic property of MIF and of its homolog DDT in NB and to predict a potential therapeutic strategy [57]. This evidence concerns the gene MIF and neuroblastoma.